Article Details

Xencor Inks Second Deal With Janssen Pharmaceuticals This Year | Los Angeles Business Journal

Retrieved on: 2021-10-11 07:05:23

Tags for this article:

Click the tags to see associated articles and topics

Xencor Inks Second Deal With Janssen Pharmaceuticals This Year | Los Angeles Business Journal. View article details on hiswai:

Excerpt

Tafasitamab is a monoclonal antibody that Xencor licensed to Planegg, Germany-based ... For antibodies that are developed without the plamotamab molecule, ...

Article found on: labusinessjournal.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up